Fusion event
HBV-TMEM232 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
TCTCAATGTTAGTATTCCTTGGACTCATAAGGTGGGGAACTTTACTGGGCTTTATTCTTCTACTGTACCTGTCTTTAATCCTCATTGGAAAACACCATCT| |TTTCCTAATATACATTTACACCAAGACATTATCAAAAAATGTGAACAGTTTGTAGGCCCACTCACAGTTAATGAGAAAAGAAGATTGCAATTGATTATGC
End
109990401/110654700 (Hg38)
Nearest miRNA
hsa-mir-10397/Upstream/140785; hsa-mir-103a-1/Downstream/5601043;
Upstream sequence
AGGAAACGCCTCCCGGCATTCAATGAAGATCGCTGATACCCAGAAGACACCCCAGTATTATGGGTGCAGTTAGTGTGTCTTTGAAAAGCTGATGATGTCT
Downstream sequence
agatggggatggcattgaatctataaattaccttgggcagtatggccattttcacgatattgattcttcctacccatgagcatggaatgttcttccattt
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.